🔬Deep Research

GSK — GSK · catalysts, narrative & risks

·17 sourcesGSK forecast →

GSK plc (LSE: GSK / NYSE: GSK) — Catalysts, Narrative, Risks, and Calendar

Not investment advice. The figures below are reported from the cited sources as of the reporting date and should be verified against primary sources before use.

Context. GSK is a FTSE 100 pharmaceutical/biotech group with a primary listing on the London Stock Exchange and ADRs on the NYSE, reporting in GBP on LSE and USD on NYSE. Reported market capitalization sits in the ~$94B range [12], [14], versus ~$122.6B cited by Wikipedia for February 2026 [17]. Below are the material developments over roughly the past one to three months (July–September 2026).

Recent catalysts (July–September 2026)


AI-assisted research from the K3vl4r desk — not personalized investment advice. More research →